Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults

NCT04546841 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

COVID-19 Vaccine

Interventions

BIOLOGICAL: multipeptide cocktail

Sponsor

University Hospital Tuebingen